Total Payments
$1,326
2024 Payments
$251.10
Companies
7
Transactions
28
Medicare Patients
19,674
Medicare Billing
$7.8M
Payment Breakdown by Category
Food & Beverage$673.97 (50.8%)
Consulting$550.00 (41.5%)
Education$101.72 (7.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $673.97 | 24 | 50.8% |
| Consulting Fee | $550.00 | 1 | 41.5% |
| Education | $101.72 | 3 | 7.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. | $550.00 | 1 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $387.75 | 19 | $0 (2024) |
| Alimera Sciences, Inc. | $200.92 | 2 | $0 (2024) |
| Shire North American Group Inc | $75.30 | 2 | $0 (2017) |
| Iridex Corporation | $70.02 | 1 | $0 (2017) |
| Genentech USA, Inc. | $29.67 | 2 | $0 (2018) |
| Allergan Inc. | $12.03 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $251.10 | 4 | Alimera Sciences, Inc. ($200.92) |
| 2023 | $141.00 | 8 | Regeneron Healthcare Solutions, Inc. ($141.00) |
| 2022 | $17.60 | 1 | Regeneron Healthcare Solutions, Inc. ($17.60) |
| 2019 | $79.22 | 4 | Regeneron Healthcare Solutions, Inc. ($79.22) |
| 2018 | $608.07 | 4 | Regeneron Pharmaceuticals, Inc. ($550.00) |
| 2017 | $228.70 | 7 | Shire North American Group Inc ($75.30) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/17/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/22/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $173.32 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 04/09/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $27.81 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/06/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 12/05/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/27/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/20/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/24/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/28/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/07/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/03/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/11/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/31/2022 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/21/2019 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/21/2019 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Education | In-kind items and services | $26.42 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/20/2019 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/13/2019 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/23/2018 | Regeneron Healthcare Solutions, Inc. | EYLEA AFLIBERCEPT INJECTION (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/05/2018 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: Ophthalmology | ||||||
| 05/18/2018 | Regeneron Healthcare Solutions, Inc. | EYLEA AFLIBERCEPT INJECTION (Biological) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/15/2018 | Regeneron Pharmaceuticals, Inc. | EYLEA AFLIBERCEPT INJECTION (Biological) | Consulting Fee | Cash or cash equivalent | $550.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/12/2017 | Shire North American Group Inc | XIIDRA (Drug) | Education | In-kind items and services | $37.65 | General |
| Category: OPTHALMICS | ||||||
| 12/12/2017 | Shire North American Group Inc | XIIDRA (Drug) | Education | In-kind items and services | $37.65 | General |
| Category: OPTHALMICS | ||||||
| 09/03/2017 | Regeneron Healthcare Solutions, Inc. | EYLEA AFLIBERCEPT INJECTION (Biological) | Food and Beverage | In-kind items and services | $28.33 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/01/2017 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 5,438 | 13,973 | $9.5M | $2.1M |
| 2022 | 16 | 5,225 | 13,474 | $8.5M | $2.0M |
| 2021 | 16 | 4,799 | 11,870 | $5.5M | $1.9M |
| 2020 | 13 | 4,212 | 11,100 | $3.8M | $1.9M |
Total Patients
19,674
Total Services
50,417
Medicare Billing
$7.8M
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 164 | 1,274 | $3.2M | $879,493 | 27.6% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 134 | 3,581 | $3.0M | $650,692 | 21.6% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 1,811 | 2,176 | $870,400 | $208,534 | 24.0% |
| 67028 | Injection of drug into eye | Office | 2023 | 321 | 1,504 | $1.4M | $143,456 | 10.2% |
| 92134 | Imaging of retina | Office | 2023 | 1,933 | 3,988 | $642,068 | $129,750 | 20.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 280 | 391 | $97,750 | $26,920 | 27.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 256 | 354 | $97,350 | $25,720 | 26.4% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 61 | 208 | $22,200 | $11,448 | 51.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 76 | 76 | $53,200 | $9,891 | 18.6% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 30 | 30 | $10,500 | $3,750 | 35.7% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 65 | 80 | $28,000 | $3,199 | 11.4% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 34 | 34 | $15,300 | $2,583 | 16.9% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 134 | 138 | $13,110 | $2,573 | 19.6% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 120 | 120 | $11,400 | $1,501 | 13.2% |
| 92250 | Photography of the retina | Office | 2023 | 19 | 19 | $4,085 | $588.04 | 14.4% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 177 | 4,208 | $3.5M | $929,567 | 26.3% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 79 | 796 | $2.0M | $570,818 | 28.7% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 1,710 | 2,076 | $830,400 | $202,875 | 24.4% |
| 67028 | Injection of drug into eye | Office | 2022 | 301 | 1,318 | $1.2M | $124,996 | 10.2% |
| 92134 | Imaging of retina | Office | 2022 | 1,769 | 3,564 | $573,804 | $118,160 | 20.6% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 283 | 385 | $105,875 | $27,691 | 26.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 263 | 353 | $88,250 | $24,760 | 28.1% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 136 | 139 | $48,650 | $15,207 | 31.3% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 101 | 101 | $45,450 | $11,161 | 24.6% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 51 | 150 | $15,000 | $7,886 | 52.6% |
About Dr. Mark Dacey, M.D
Dr. Mark Dacey, M.D is a Retina Specialist healthcare provider based in East Weymouth, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1184613192.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Dacey, M.D has received a total of $1,326 in payments from pharmaceutical and medical device companies, with $251.10 received in 2024. These payments were reported across 28 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($673.97).
As a Medicare-enrolled provider, Dacey has provided services to 19,674 Medicare beneficiaries, totaling 50,417 services with total Medicare billing of $7.8M. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Retina Specialist
- Other Specialties Ophthalmology
- Location East Weymouth, MA
- Active Since 10/21/2005
- Last Updated 12/20/2021
- Taxonomy Code 207WX0107X
- Entity Type Individual
- NPI Number 1184613192
Products in Payments
- EYLEA AFLIBERCEPT INJECTION (Biological) $649.75
- YUTIQ (Drug) $200.92
- EYLEA (Biological) $183.98
- EYLEA HD (Biological) $104.02
- XIIDRA (Drug) $75.30
- Lucentis (Biological) $29.67
- RESTASIS (Drug) $12.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.